Unlike the presented pilot run of the discrete event simulation model these costs refer to the lifetime costs of a venous leg ulcer and are not meant per year. Considering that the average duration of a venous leg ulcer is 8.9 years, 7 also in Germany costs savings in the middle four-figure range per patient can be recorded.
Methodology II
Chronic leg ulcer (fig 1) is defined as a defect in the skin below the level of knee persisting for more than six weeks and shows no tendency to heal after three or more months. 1 The condition affects 1% of the adult population and 3.6% of people older than 65 years. 2 According to a study carried out in Germany, venous insufficiency was the dominating causative factor in 47.6% of leg ulcers, arterial insufficiency 14.5% and combined arterial and venous 17.6%. 3 Medical compression therapy to the lower limb (fig 2-3 ) is the single most important factor in the conservative treatment of venous leg ulcers and combined etiology where the ulcer is more predominately venous. 4 Due to the demographic change and the increasing number of vascular diseases with elderly people, an additional increase of chronic leg ulcers is to be expected. The longterm healing prognosis for leg ulcer patients is poor and worst for patients with venous ulcers especially without compression therapy.
Despite the proven effectiveness of compression therapy there is still an underuse with compression therapy in venous leg ulcers. According to current data of a statutory health insurance fund in Germany, the proportion of treatment with compression therapy in venous leg ulcers is under 50% (fig 6) . 5 But which regional savings may be achieved by guideline-based implementation with compression therapy? This means, what savings per federal state can be expected by treating all venous leg ulcers with compression therapy?
The average costs for compression therapy are 230 € per patient and year. Despite the costs, a pilot run of the model analyses indicates that the costs of n = 100 patients per group, who are treated without compression therapy, are 40,295 € higher per year than the costs of patients treated with compression therapy (fig 7) . This difference of 403 € per patient and year is caused by the significant shorter healing times, which were implemented in the model. 
